ENTRY       hsa05415                    Pathway
NAME        Diabetic cardiomyopathy - Homo sapiens (human)
DESCRIPTION Diabetic cardiomyopathy has been defined as left ventricular dysfunction that occurs among patients with diabetes mellitus independent of a recognized cause such as coronary artery disease or hypertension. The pathogenesis of diabetic cardiomyopathy broadly involves hyperglycemia, increased circulating fatty acids, and insulin resistance contributing to reactive oxygen species (ROS) generation, mitochondrial dysfunction, impaired calcium metabolism, Renin-Angiotensin System (RAS) activation, and altered substrate metabolism. These effects result in cardiac fibrosis, hypertrophy, cardiomyocyte death, contractile dysfunction, endothelial cell damage and eventually heart failure. In the process of cardiac fibrosis, cardiac fibroblasts are the final effector cell.
CLASS       Human Diseases; Cardiovascular disease
PATHWAY_MAP hsa05415  Diabetic cardiomyopathy
DISEASE     H02498  Diabetic cardiomyopathy
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]
            10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
            10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]
            107984365  [KO:K03948]
            10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            1215  CMA1; chymase 1 [KO:K01329] [EC:3.4.21.39]
            125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]
            126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]
            1277  COL1A1; collagen type I alpha 1 chain [KO:K06236]
            1278  COL1A2; collagen type I alpha 2 chain [KO:K06236]
            1281  COL3A1; collagen type III alpha 1 chain [KO:K19720]
            1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]
            1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]
            1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]
            1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]
            1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]
            1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]
            1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]
            1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]
            1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]
            1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]
            1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]
            1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]
            1376  CPT2; carnitine palmitoyltransferase 2 [KO:K08766] [EC:2.3.1.21]
            142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K24070]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]
            1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]
            1536  CYBB; cytochrome b-245 beta chain [KO:K21421] [EC:1.-.-.-]
            1537  CYC1; cytochrome c1 [KO:K00413]
            1636  ACE; angiotensin I converting enzyme [KO:K01283] [EC:3.4.15.1]
            170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]
            177  AGER; advanced glycosylation end-product specific receptor [KO:K19722]
            183  AGT; angiotensinogen [KO:K09821]
            185  AGTR1; angiotensin II receptor type 1 [KO:K04166]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            2539  G6PD; glucose-6-phosphate dehydrogenase [KO:K00036] [EC:1.1.1.49 1.1.1.363]
            25874  MPC2; mitochondrial pyruvate carrier 2 [KO:K22139]
            2597  GAPDH; glyceraldehyde-3-phosphate dehydrogenase [KO:K00134] [EC:1.2.1.12]
            2673  GFPT1; glutamine--fructose-6-phosphate transaminase 1 [KO:K00820] [EC:2.6.1.16]
            27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]
            291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
            292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
            293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            2936  GSR; glutathione-disulfide reductase [KO:K00383] [EC:1.8.1.7]
            29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]
            2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]
            2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]
            341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]
            347411  MPC1L; mitochondrial pyruvate carrier 1 like [KO:K22138]
            3630  INS; insulin [KO:K04526]
            3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
            3667  IRS1; insulin receptor substrate 1 [KO:K16172]
            374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]
            4087  SMAD2; SMAD family member 2 [KO:K04500]
            4088  SMAD3; SMAD family member 3 [KO:K23605]
            4313  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]
            4318  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]
            440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]
            4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]
            4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]
            4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]
            4513  COX2; cytochrome c oxidase subunit II [KO:K02261]
            4514  COX3; cytochrome c oxidase subunit III [KO:K02262]
            4519  CYTB; cytochrome b [KO:K00412]
            4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]
            4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]
            4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]
            4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]
            4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]
            4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]
            4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]
            4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]
            4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]
            4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]
            4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]
            4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]
            4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]
            4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]
            4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]
            4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]
            4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]
            4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]
            4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]
            4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]
            4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]
            4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]
            4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]
            4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]
            4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]
            4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]
            4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]
            4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]
            4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]
            4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]
            4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]
            4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]
            4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]
            4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]
            4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]
            4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]
            4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]
            4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]
            4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]
            4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]
            4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]
            4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]
            487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:7.2.2.10]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
            489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
            498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]
            506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]
            509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]
            51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]
            513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]
            514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]
            515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]
            516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]
            5160  PDHA1; pyruvate dehydrogenase E1 subunit alpha 1 [KO:K00161] [EC:1.2.4.1]
            5161  PDHA2; pyruvate dehydrogenase E1 subunit alpha 2 [KO:K00161] [EC:1.2.4.1]
            5162  PDHB; pyruvate dehydrogenase E1 subunit beta [KO:K00162] [EC:1.2.4.1]
            5164  PDK2; pyruvate dehydrogenase kinase 2 [KO:K00898] [EC:2.7.11.2]
            5165  PDK3; pyruvate dehydrogenase kinase 3 [KO:K00898] [EC:2.7.11.2]
            5166  PDK4; pyruvate dehydrogenase kinase 4 [KO:K00898] [EC:2.7.11.2]
            51660  MPC1; mitochondrial pyruvate carrier 1 [KO:K22138]
            517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]
            518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]
            522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            5350  PLN; phospholamban [KO:K05852]
            539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]
            54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]
            5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]
            5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
            5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
            5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
            5524  PTPA; protein phosphatase 2 phosphatase activator [KO:K17605]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]
            55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]
            5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5880  RAC2; Rac family small GTPase 2 [KO:K07860]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            5972  REN; renin [KO:K01380] [EC:3.4.23.15]
            6262  RYR2; ryanodine receptor 2 [KO:K04962]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]
            6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]
            6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]
            6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]
            6513  SLC2A1; solute carrier family 2 member 1 [KO:K07299]
            6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]
            653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]
            6667  SP1; Sp1 transcription factor [KO:K04684]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            7046  TGFBR1; transforming growth factor beta receptor 1 [KO:K04674] [EC:2.7.11.30]
            7048  TGFBR2; transforming growth factor beta receptor 2 [KO:K04388] [EC:2.7.11.30]
            7137  TNNI3; troponin I3, cardiac type [KO:K12044]
            7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]
            7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]
            7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]
            7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]
            7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]
            7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]
            7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]
            7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]
            815  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
            816  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
            817  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
            818  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
            83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
            84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]
            9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]
            948  CD36; CD36 molecule (CD36 blood group) [KO:K06259]
            9882  TBC1D4; TBC1 domain family member 4 [KO:K17902]
            9945  GFPT2; glutamine-fructose-6-phosphate transaminase 2 [KO:K00820] [EC:2.6.1.16]
COMPOUND    C00001  H2O
            C00002  ATP
            C00005  NADPH
            C00006  NADP+
            C00022  Pyruvate
            C00024  Acetyl-CoA
            C00027  Hydrogen peroxide
            C00031  D-Glucose
            C00043  UDP-N-acetyl-alpha-D-glucosamine
            C00051  Glutathione
            C00076  Calcium cation
            C00085  D-Fructose 6-phosphate
            C00092  D-Glucose 6-phosphate
            C00095  D-Fructose
            C00118  D-Glyceraldehyde 3-phosphate
            C00127  Glutathione disulfide
            C00162  Fatty acid
            C00165  Diacylglycerol
            C00195  N-Acylsphingosine
            C00236  3-Phospho-D-glyceroyl phosphate
            C00318  L-Carnitine
            C00352  D-Glucosamine 6-phosphate
            C00369  Starch
            C00533  Nitric oxide
            C00546  Methylglyoxal
            C00704  Superoxide
            C00794  D-Sorbitol
            C00873  Angiotensin I
            C02135  Angiotensin II
            C02843  Long-chain acyl-CoA
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C06156  alpha-D-Glucosamine 1-phosphate
            C16844  Hydroxyl radical
            C21011  [Protein]-N(epsilon)-(carboxymethyl)lysine
            C21012  [Protein]-N(epsilon)-(carboxyethyl)lysine
            C21013  [Protein]-pyrraline
            C21014  [Protein]-pentosidine
            C22310  Fructose 3-phosphate
            C22311  3-Deoxyglucosone
REFERENCE   PMID:30443826
  AUTHORS   Riehle C, Bauersachs J
  TITLE     Of mice and men: models and mechanisms of diabetic cardiomyopathy.
  JOURNAL   Basic Res Cardiol 114:2 (2018)
            DOI:10.1007/s00395-018-0711-0
REFERENCE   PMID:24462787
  AUTHORS   Huynh K, Bernardo BC, McMullen JR, Ritchie RH
  TITLE     Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
  JOURNAL   Pharmacol Ther 142:375-415 (2014)
            DOI:10.1016/j.pharmthera.2014.01.003
REFERENCE   PMID:28231848
  AUTHORS   Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O
  TITLE     Diagnostic approaches for diabetic cardiomyopathy.
  JOURNAL   Cardiovasc Diabetol 16:28 (2017)
            DOI:10.1186/s12933-017-0506-x
REFERENCE   PMID:32080423
  AUTHORS   Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L
  TITLE     Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
  JOURNAL   Nat Rev Cardiol 17:585-607 (2020)
            DOI:10.1038/s41569-020-0339-2
REFERENCE   PMID:31212580
  AUTHORS   Zamora M, Villena JA
  TITLE     Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.
  JOURNAL   Int J Mol Sci 20:E2833 (2019)
            DOI:10.3390/ijms20112833
REFERENCE   PMID:29605388
  AUTHORS   Palomer X, Pizarro-Delgado J, Vazquez-Carrera M
  TITLE     Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
  JOURNAL   Trends Pharmacol Sci 39:452-467 (2018)
            DOI:10.1016/j.tips.2018.02.010
REFERENCE   PMID:28439258
  AUTHORS   Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK
  TITLE     Diabetic Cardiomyopathy: An Immunometabolic Perspective.
  JOURNAL   Front Endocrinol (Lausanne) 8:72 (2017)
            DOI:10.3389/fendo.2017.00072
REFERENCE   PMID:28177068
  AUTHORS   Chong CR, Clarke K, Levelt E
  TITLE     Metabolic Remodeling in Diabetic Cardiomyopathy.
  JOURNAL   Cardiovasc Res 113:422-430 (2017)
            DOI:10.1093/cvr/cvx018
REFERENCE   PMID:11742414
  AUTHORS   Brownlee M
  TITLE     Biochemistry and molecular cell biology of diabetic complications.
  JOURNAL   Nature 414:813-20 (2001)
            DOI:10.1038/414813a
REFERENCE   PMID:32821697
  AUTHORS   Gollmer J, Zirlik A, Bugger H
  TITLE     Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
  JOURNAL   J Lipid Atheroscler 8:26-47 (2019)
            DOI:10.12997/jla.2019.8.1.26
REFERENCE   PMID:17592090
  AUTHORS   Boudina S, Abel ED
  TITLE     Diabetic cardiomyopathy revisited.
  JOURNAL   Circulation 115:3213-23 (2007)
            DOI:10.1161/CIRCULATIONAHA.106.679597
REFERENCE   PMID:29109032
  AUTHORS   Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD
  TITLE     Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
  JOURNAL   Biochim Biophys Acta Mol Basis Dis 1864:1949-1959 (2018)
            DOI:10.1016/j.bbadis.2017.10.035
REFERENCE   PMID:23147391
  AUTHORS   Mandavia CH, Aroor AR, Demarco VG, Sowers JR
  TITLE     Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
  JOURNAL   Life Sci 92:601-8 (2013)
            DOI:10.1016/j.lfs.2012.10.028
REFERENCE   PMID:21626163
  AUTHORS   Falcao-Pires I, Leite-Moreira AF
  TITLE     Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
  JOURNAL   Heart Fail Rev 17:325-44 (2012)
            DOI:10.1007/s10741-011-9257-z
REFERENCE   PMID:27148064
  AUTHORS   Westermeier F, Riquelme JA, Pavez M, Garrido V, Diaz A, Verdejo HE, Castro PF, Garcia L, Lavandero S
  TITLE     New Molecular Insights of Insulin in Diabetic Cardiomyopathy.
  JOURNAL   Front Physiol 7:125 (2016)
            DOI:10.3389/fphys.2016.00125
REFERENCE   PMID:33276047
  AUTHORS   Randhawa VK, Dhanvantari S, Connelly K
  TITLE     How Diabetes and Heart Failure Modulate Each Other and Condition Management.
  JOURNAL   Can J Cardiol S0828-282X(20)31115-6 (2020)
            DOI:10.1016/j.cjca.2020.11.014
REFERENCE   PMID:31641426
  AUTHORS   Athithan L, Gulsin GS, McCann GP, Levelt E
  TITLE     Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.
  JOURNAL   World J Diabetes 10:490-510 (2019)
            DOI:10.4239/wjd.v10.i10.490
REFERENCE   PMID:21111987
  AUTHORS   Murarka S, Movahed MR
  TITLE     Diabetic cardiomyopathy.
  JOURNAL   J Card Fail 16:971-9 (2010)
            DOI:10.1016/j.cardfail.2010.07.249
REFERENCE   PMID:25085967
  AUTHORS   Thomas CM, Yong QC, Rosa RM, Seqqat R, Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM, Kumar R
  TITLE     Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
  JOURNAL   Am J Physiol Heart Circ Physiol 307:H1036-45 (2014)
            DOI:10.1152/ajpheart.00340.2014
REFERENCE   PMID:28236380
  AUTHORS   Brahma MK, Pepin ME, Wende AR
  TITLE     My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.
  JOURNAL   Diabetes Metab J 41:1-9 (2017)
            DOI:10.4093/dmj.2017.41.1.1
REFERENCE   PMID:18829990
  AUTHORS   Singh VP, Le B, Khode R, Baker KM, Kumar R
  TITLE     Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis.
  JOURNAL   Diabetes 57:3297-306 (2008)
            DOI:10.2337/db08-0805
REFERENCE   PMID:18296558
  AUTHORS   Singh VP, Baker KM, Kumar R
  TITLE     Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
  JOURNAL   Am J Physiol Heart Circ Physiol 294:H1675-84 (2008)
            DOI:10.1152/ajpheart.91493.2007
REFERENCE   PMID:26678809
  AUTHORS   Jia G, DeMarco VG, Sowers JR
  TITLE     Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
  JOURNAL   Nat Rev Endocrinol 12:144-53 (2016)
            DOI:10.1038/nrendo.2015.216
REFERENCE   PMID:18309108
  AUTHORS   Kim JA, Wei Y, Sowers JR
  TITLE     Role of mitochondrial dysfunction in insulin resistance.
  JOURNAL   Circ Res 102:401-14 (2008)
            DOI:10.1161/CIRCRESAHA.107.165472
REFERENCE   PMID:30170598
  AUTHORS   Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA
  TITLE     Association between insulin resistance and the development of cardiovascular disease.
  JOURNAL   Cardiovasc Diabetol 17:122 (2018)
            DOI:10.1186/s12933-018-0762-4
REFERENCE   PMID:31269778
  AUTHORS   Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A
  TITLE     Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
  JOURNAL   Int J Mol Sci 20:E3264 (2019)
            DOI:10.3390/ijms20133264
REFERENCE   PMID:24307101
  AUTHORS   Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N
  TITLE     Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.
  JOURNAL   Mol Cell Biochem 386:233-49 (2014)
            DOI:10.1007/s11010-013-1861-x
REFERENCE   PMID:29867137
  AUTHORS   Knapp M, Tu X, Wu R
  TITLE     Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
  JOURNAL   Acta Pharmacol Sin 40:1-8 (2019)
            DOI:10.1038/s41401-018-0042-6
REFERENCE   PMID:16487830
  AUTHORS   Asbun J, Villarreal FJ
  TITLE     The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy.
  JOURNAL   J Am Coll Cardiol 47:693-700 (2006)
            DOI:10.1016/j.jacc.2005.09.050
REFERENCE   PMID:32024054
  AUTHORS   Levick SP, Widiapradja A
  TITLE     The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function.
  JOURNAL   Int J Mol Sci 21:E970 (2020)
            DOI:10.3390/ijms21030970
REL_PATHWAY hsa00010  Glycolysis / Gluconeogenesis
            hsa00020  Citrate cycle (TCA cycle)
            hsa00190  Oxidative phosphorylation
            hsa00520  Amino sugar and nucleotide sugar metabolism
            hsa03320  PPAR signaling pathway
            hsa04071  Sphingolipid signaling pathway
            hsa04150  mTOR signaling pathway
            hsa04210  Apoptosis
            hsa04260  Cardiac muscle contraction
            hsa04350  TGF-beta signaling pathway
            hsa04614  Renin-angiotensin system
            hsa04910  Insulin signaling pathway
            hsa04930  Type II diabetes mellitus
            hsa04931  Insulin resistance
            hsa04933  AGE-RAGE signaling pathway in diabetic complications
            hsa04940  Type I diabetes mellitus
KO_PATHWAY  ko05415
///
